Abstracts

Pediatric Oncology Use of Cabozantinib in addition to chemotherapy as a viable second line treatment option in Relapsed Refractory Malignant Osteogenic Sarcomas
Dale Jude Montes • Maharshi Trivedi • Helie Raval • Himangi Tak • Chinmay Doctor • Harsha Panchal
doi.org/10.69690/ODMJ-018-0425-2488
Pediatric Oncology Pediatric Lymphoblastic Lymphoma: Clinical course, challenges and treatment strategies
Ruksana Sidhique • Nikita Jakhar • Sharan Shanubhogue • Jagdish Prasad Meena • Aditya Kumar Gupta
doi.org/10.69690/ODMJ-018-0425-2477
Pediatric Oncology Elevated Procalcitonin and Proadrenomedullin Levels at Diagnosis and During Febrile Neutropenia in Pediatric Acute Leukemia: A Prospective Study from a Tertiary Care Center
Ruksana Sidhique • Jagdish Prasad Meena • Harshita Makkar • Aditya Kumar Gupta • Ashutosh Halder • Rachna Seth
doi.org/10.69690/ODMJ-018-0425-2475
Pediatric Oncology Pediatric desmoid fibromatosis – Experience from a tertiary care cancer hospital
Dale Jude Montes • Maharshi Trivedi • Helie Raval • Chinmay Doctor • Harsha Panchal
doi.org/10.69690/ODMJ-018-0425-2471
Pediatric Oncology NCI Standard risk B-cell Acute Lymphoblastic Leukemia – Ten year outcome from India. Where are we heading towards?
Annapoorani Ramasamy • Venkateshwaran VS
doi.org/10.69690/ODMJ-018-0425-2468
Pediatric Oncology Profile of neuroblastoma – experience from a tertiary paediatric oncology centre from a developing country
Rishab Bhurat • Mohanaraj Ramachandran • Julius Scott • Ashwini Arul • Latha M. Sneha • Madhu S • Satish Srinivas • Rajeswaran Rangasami • Leena Dennis Joseph
doi.org/10.69690/ODMJ-018-0425-2457
Pediatric Oncology Belumosudil is effective in Pediatric Patients with chronic Graft-versus-Host disease after failed Ruxolitinib treatment
Yuanyuan Chen • Xiaojun Xu • Fenfen Jin
doi.org/10.69690/ODMJ-018-0425-2454
Pediatric Oncology B-cell precursor Acute Lymphoblastic Leukemia with high hyperdiploidy who have detectable residual disease at the end of induction can be salvaged by treatment escalation
Aniruddha Rathore • Chetan Dhamne • Nirmalya Roy Moulik • Shyam Srinivasan • Akanksha Chichra • Vikramraj Gokhale • Ruchika Gavanang • Shripad Banavali • Gaurav Narula
doi.org/10.69690/ODMJ-018-0425-2439
Pediatric Oncology Treatment outcomes and late effects in Retinoblastoma survivors: Importance of survivor clinics
Rachna Seth • Bhavna Chawla
doi.org/10.69690/ODMJ-018-0425-2426
Pediatric Oncology Bacterial infections and paediatric cancer: Change in trends of pathogens from an Indian Centre
Shubhashree Acharya • Debabrata Mohapatra • Sanghamitra Padhi • Susmita Kumari Sahu • Hemanta Kumar Singh • Debashish Mishra
doi.org/10.69690/ODMJ-018-0425-2438
Pediatric Oncology Novel therapies in pediatric cancer care: A retrospective study from Armenia
Elya Minasyan • Ruzanna Papyan • Irina Melnichenko • Saten Hovhannisyan • Lusine Hakobyan • Samvel Iskanyan • Mariam Minasyan • Hayk Grigoryan • Gevorg Tamamyan • Lilit Sargsyan
doi.org/10.69690/ODMJ-018-0425-2393
Pediatric Oncology Risk Factors for Relapse in Children with Hodgkin Lymphoma treated with Chemotherapy alone Protocols
Neetipriya Pandey • Priyanka Aggarwal • Vineeta Gupta
doi.org/10.69690/ODMJ-018-0425-2428